Back to results
CompletedPhase 3

Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

NCT05110170

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Zhejiang Cancer Hospital

Hangzhou, China

View on ClinicalTrials.gov
Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® — TrialFind